BMG LABTECH & InvivoSciences Collaborate to Accelerate Drug Discovery in Engineered 3D Tissues
November 17, 2013
Cary, NC - BMG LABTECH, Inc. - the Microplate Reader Company - and InvivoSciences, Inc. - a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery - announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader technologies. Employing an [...]
Oxford Nanopore announces secondary placing, divestment of Illumina
November 15, 2013
Oxford, UK. Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has co-ordinated a secondary placing of shares on behalf of certain shareholders. The majority of this transaction was the acquisition of Illumina's 13.5% shareholding in Oxford Nanopore by other investors for £56.4 million. Oxford Nanopore announced in October [...]
736 Series: Oxygen/Nitrogen Analysis by Fusion
November 15, 2013
St. Joseph, Mich. — LECO has introduced the 736 Series, an oxygen/nitrogen analyzer developed for accurate wide-range measurement of oxygen and nitrogen content of inorganic materials, ferrous and nonferrous alloys, and refractory materials using the inert gas fusion technique. The 736 Series features an improved detector design with thermostatic construction and increased protection for ambient [...]
November 15, 2013
NEW YORK, NY, -- Enzo Biochem Inc. (NYSE:ENZ) today announced publication of a study in a leading scientific journal, Modern Pathology, a Nature Publishing Group publication, that shows a strong association of idiopathic pulmonary fibrosis (IPF), a pulmonary disease with 100% mortality within five years, with the presence of the herpesvirus saimiri virus, a virus [...]
November 15, 2013
RAMSEY, N.J -- Konica Minolta Sensing Americas, Inc. (KMSA), the worldwide leader in the industrial measurement of color and light, is continuing to build on its industry-leading position in light and display measurement technology by exploring new business opportunities and gaining entry into new markets with the newly acquired Instrument Systems GmbH (IS) product line. [...]
Anton Paar acquires CSM Instruments: The measuring instrument manufacturer expands its portfolio
November 15, 2013
Anton Paar GmbH – manufacturer of high-precision instruments for the laboratory and production process, with its headquarters in Graz, Austria – has acquired CSM Instruments SA in Switzerland as of November 15. CSM Instruments SA will continue under the name "CSM Instruments SA | A company of Anton Paar" at the present location in Peseux [...]
November 15, 2013
De Pere, WI -- Hamilton Scientific of De Pere, Wisconsin recently completed the installation of 60 fume hoods and 120 laboratory benches in the 200,000 sq. ft. lab space at the Wisconsin Energy Institute & Consolidated Forensic Lab. The new, contemporary laboratory workstation design was developed in response to the customer’s request for utility access [...]
StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer
November 14, 2013
NEWARK, Calif. -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, today announced that Greg Schiffman will join its executive team as Chief Financial Officer and Executive Vice President of Finance, effective January 1, 2014. In his new role, Mr. Schiffman will be responsible [...]
Perten receives NTEP certification for IM 9500
November 14, 2013
Perten Instruments receives NTEP certification for whole grain NIR analysis of moisture, protein, oil and test weight Industry standard NIR transmittance technology employed for accurate, timely analysis. Perten Instruments announced that its IM 9500 Whole Grain NIR has received Certificate of Conformance for National Type Equipment Program (NTEP). NTEP approval means that the IM 9500 [...]
GENAPSYS™, INC. RAISES $37M TO COMMERCIALIZE NEXT GENERATION SEQUENCING PLATFORM
November 14, 2013
Redwood City, California –– GenapSys™, Inc. (GenapSys), a provider of Next Generation Sequencing (NGS) systems, today announced it has raised $37M to commercialize the GENIUS™ 110 system (Gene Electronic Nano-Integrated Ultra-Sensitive), a fully integrated DNA Sequencing system for the rapidly evolving NGS market. The Series B financing includes new investors Yuri Milner, Stanford StartX Fund, [...]

